VIPULKUMAR DEVANI: Open Payments
NPI 1619577723 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,336 in 199 payments from 21 companies in 2025. Trend: 2023 $2,890 · 2024 $3,516 · 2025 $3,336
Food & beverage: $3,326Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $512 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $501 |
| Axsome Therapeutics, Inc. | 17 | $261 |
| E.R. Squibb & Sons, L.L.C. | 8 | $233 |
| Otsuka America Pharmaceutical, Inc. | 13 | $224 |
| Corium, LLC | 15 | $220 |
| Supernus Pharmaceuticals, Inc. | 13 | $217 |
| Neurocrine BioSciences, Inc. | 10 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $182 |
| Lundbeck LLC | 9 | $155 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, COBENFY, Azstarys, Qelbree, INGREZZA.
Industry payments across AZ — which companies pay providers there.
